Otrivin Comp nasal spray

Otrivin is a globally recognized brand specializing in nasal decongestants and respiratory health. The brand has its historical roots in Switzerland, where it was originally launched in 1956 by the pharmaceutical company Ciba (which later became Ciba-Geigy and eventually Novartis through mergers). Over the decades, it evolved through significant corporate restructuring involving GlaxoSmithKline (GSK) and Novartis.

Today, Otrivin is owned by Haleon plc, a British multinational consumer healthcare company based in Weybridge, England. Haleon was established in 2022 as a major spin-off from GSK’s consumer healthcare division, consolidating a massive portfolio of power brands like Sensodyne, Advil, and Voltarol. While the brand remains headquartered in the UK, manufacturing of Otrivin products occurs globally across several specialized pharmaceutical facilities in Europe (including Slovakia and Switzerland) and Asia to meet international demand.